Related Experiment Video

Updated: May 4, 2026

Automating Tumor Implantation in Zebrafish Larvae for Cancer Research and Medicine
06:14

Automating Tumor Implantation in Zebrafish Larvae for Cancer Research and Medicine

Published on: September 19, 2025

1.2K

Testicular cancer in 2013: towards personalized medicine--are we there yet?

Jan Oldenburg1, Sophie D Fosså1

  • 1Department of Oncology, Oslo University Hospital, Ullernchausseen 70, Oslo 0313, Norway.

Nature Reviews. Urology
|December 25, 2013
PubMed

Insights

New testicular cancer treatments in 2013 offered alternatives to standard chemotherapy for patients with poor prognoses. This progress highlights a move towards personalized, less intensive approaches for this curable cancer.

Area of Science:

  • Oncology
  • Medical Research

Background:

  • Testicular cancer treatment has historically involved intensive chemotherapy regimens.
  • Reduced-intensity treatment options are crucial for improving patient outcomes and minimizing toxicity.

Purpose of the Study:

  • To explore advancements in reduced-intensity treatments for testicular cancer.
  • To identify alternative therapeutic strategies for patients with metastatic disease and poor prognoses.

Main Methods:

  • Review of treatment developments in testicular cancer during 2013.
  • Identification of novel chemotherapy alternatives to bleomycin, etoposide, and cisplatin.

Main Results:

  • An alternative chemotherapy regimen emerged for testicular cancer patients with poor prognoses.
  • Progress was made in developing less intensive treatment options.

Conclusions:

  • Advancements in 2013 indicate a shift towards personalized medicine in testicular cancer care.
  • Reduced-intensity treatments are becoming a viable option for improving outcomes in testicular cancer.

More Related Videos

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

6.5K
Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

19.4K

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.0K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.4K
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
51.7K
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

1.1K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K